Treatment group: Clinical Trials

80 trials of Treatment group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 16 unknown, 9 recruiting, 8 not yet recruiting. 46 Not applicable, 19 Phase 2, 6 Phase 4, 5 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable46Completed 21, Not yet recruiting 6, Recruiting 6, Unknown 5, Terminated 4, Withdrawn 3, Active not recruiting 1
Phase 219Unknown 7, Completed 6, Not yet recruiting 2, Recruiting 2, Terminated 2
Phase 46Completed 2, Unknown 2, Recruiting 1, Withdrawn 1
Phase 15Unknown 3, Completed 2
Phase 35Completed 2, Unknown 2, Recruiting 1
Early Phase 11Completed 1

Follow Treatment group: new trials by email Literature Review of Treatment group trials Research Report on Treatment group

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease
Non-compliant Plain Balloon angioplasty (PBA), Non-compliant Scoring Balloon Angioplasty (SB) - Femoropopliteal Disease, Drug Coated Balloon
Not applicableNot yet recruitingMarc Sirvent1422026-12-012026-10-07
Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
Treatment group - Weight Loss
Not applicableRecruitingBoston Scientific Corporation1442026-06-032026-09-25
Clinical Study of BMP-2 Injectable Hydrogel for Promoting Alveolar Bone Regeneration
treatment group - Periodontitis, Alveolar Bone Loss* / Therapy
Not applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical College802026-05-012026-05-28
Clinical Study of Minocycline Hydrochloride Injectable Hydrogel for the Treatment of Periodontitis
treatment group - Periodontitis
Not applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical College802026-05-012026-05-28
PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy
PSYCHOPATHY.COMP, Treatment as Usual (TAU) - Antisocial Personality Disorder (ASPD)
Not applicableRecruitingUniversity of Coimbra2002026-04-062026-09-10
A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer
treatment group - TNBC
Not applicableNot yet recruitingTianjin Medical University Cancer Institute and Hospital432026-03-252026-03-24
Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas
Shenbai Granules, Placebo - Colorectal Adenoma, High Risk
Not applicableNot yet recruitingJiangsu Famous Medical Technology Co., Ltd.4502025-08-152025-08-19
Physiotherapy After Emergency Laparotomy in the Elderly
Experimental (Structured postoperative physiotherapy), Standard postoperative care - Emergency Abdominal Surgery
Not applicableRecruitingUniversity of Cyprus2502025-07-132026-03-31
Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
Treatment group, Standard-of-care control group - Metastatic Colorectal Cancer
Phase 2Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences1302025-04-092025-03-05
NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
Home hospitalization - Stroke (CVA) or TIA, Stroke Recurrence
Not applicableRecruitingHospital Universitari Vall d'Hebron Research Institute2502025-01-292026-03-30
Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC
Intensity-modulated radiation therapy (IMRT) in combination with fluzoparib, abiraterone acetate tablets (II), and prednisone. - Metastatic Castration-resistant Prostate Cancer
Phase 2RecruitingJianbin Bi402024-11-272025-05-14
Effect of an Oral Frailty Measures Intervention Programs in Institutionalized Elders
treatment group, Contral group - Frailty
Not applicableNot yet recruitingHangzhou Normal University2262024-11-112024-11-04
The Effect of a Prolonged Peripheral Nerve Block on the Level of Pain After a Knee Replacement
Continues peripheral block - Knee Replacement Surgery
Not applicableUnknownAssaf-Harofeh Medical Center502024-10-302024-04-24
Clinical Study on the Combination of Xiaoyu Zhitong Formula and Lymphatic Drainage Technique to Improve the Symptoms of Knee Pain and Swelling in Cold Dampness Obstruction Type
treatment group, control group - Knee Osteoarthritis (OA)
Enrolling by invitationtang jie1002024-10-102025-04-04
Efficacy of Early Postoperative ON101 Application for Lower-extremity Fracture Incisions: a Prospective Evaluator-blinded Controlled Study of Scar Quality and Digital-clinical Concordance
ON101 - Wound Healing
Not applicableCompletedLIN Kai-Cheng302024-09-102026-10-05
Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents
0.01mg/kg DGPR1008 Injection Dose Group 1 (n=6), 0.02mg/kg DGPR1008 Injection Dose Group 2 (n=6), 0.04mg/kg DGPR1008 Injection Dose Group 3 (n=6) - Prostate Cancer Patients Undergoing Radical Prostatectomy, Prostate CA
Phase 1CompletedHaitao Niu, MD322024-06-242025-08-03
Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
Intrathecal Nicardipine, No intervention - Aneurysmal Subarachnoid Hemorrhage, Vasospasm
Not applicableRecruitingThe Affiliated Hospital Of Guizhou Medical University3962024-05-272025-09-08
Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.
Linperlisib in combination with Obinutuzumab and Venetoclax - Mantle Cell Lymphoma
Phase 2Not yet recruitingDalian Medical University102024-05-012024-03-22
Effects of Physical Activiy Promotion Intervention Programs in Emerging Adulthood
Treatment group, Contral group - Body Composition, Health Behavior
Not applicableCompletedXu Tao1572023-06-282024-08-19
Monolaurin Ointment Versus Mupirocin Ointment
Monolaurin, Mupirocin ointment - Bacterial Infections
Early Phase 1CompletedVictoriano Luna Medical Center402023-06-012023-10-17

Showing 20 of 80. Sign in to see all of them.

Conditions studied

Stomach Neoplasms (5)  ·  COVID-19 (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Chronic Limb-Threatening Ischemia (2)  ·  Colitis, Ulcerative (2)  ·  Depression (2)  ·  Diabetes Mellitus (2)  ·  Hypertension (2)  ·  Myocardial Infarction (2)  ·  Pain (2)  ·  Periodontitis (2)  ·  Peripheral Arterial Disease (2)  ·  Renal Insufficiency, Chronic (2)  ·  Stroke (2)  ·  Uterine Cervical Neoplasms (2)

Sponsors

Fudan University (5)  ·  Shanghai Institute of Acupuncture, Moxibustion and Meridian (3)  ·  The Affiliated Hospital of Xuzhou Medical University (3)  ·  Marc Sirvent (2)  ·  The First Affiliated Hospital of Xinxiang Medical College (2)  ·  University of Sao Paulo (2)  ·  Abbott Medical Devices (1)  ·  Adistem Ltd (1)  ·  Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran (1)  ·  Anhui Provincial Hospital (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Bangkok Metropolitan Administration Medical College and Vajira Hospital (1)  ·  Baylor College of Medicine (1)  ·  Beijing 302 Hospital (1)  ·  Beijing Municipal Science & Technology Commission (1)

Countries

China (27)  ·  United States (14)  ·  Indonesia (3)  ·  Brazil (2)  ·  Canada (2)  ·  Germany (2)  ·  Philippines (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Argentina (1)  ·  Australia (1)  ·  Cameroon (1)  ·  Cyprus (1)  ·  Egypt (1)  ·  Iran (1)

Top investigators

Dong Sun, MD (2)  ·  Huangan Wu, Doctor (2)  ·  Jin Li, PhD, M.D. (2)  ·  Wenjie Ren (2)  ·  Ade Meidian Ambari, MD,FIHA (1)  ·  Anthony R Carlini, MS (1)  ·  Armin N Flinspach, MD (1)  ·  Asle Hoffart, PhD (1)  ·  Bill Paspaliaris, PhD (1)  ·  Corby K Martin, PhD (1)  ·  David Kulber, MD (1)  ·  Deborah A Levesque, Ph.D. (1)  ·  Dr Gabriel Loni Ekali, MD (1)  ·  Dr Marcel Azabji Kenfack, MD (1)  ·  Dr Sobngwi Eugene, MD, PhD (1)

Results publications

PMID 10390314, PMID 11726736, PMID 11950405, PMID 14567598, PMID 15309916, PMID 17029347, PMID 17185636, PMID 17510057, PMID 17695377, PMID 18494776, PMID 18992868, PMID 19359629, PMID 1944936, PMID 19668980, PMID 19710204, PMID 19781687, PMID 19934963, PMID 20595669, PMID 20798370, PMID 21116906, PMID 21285966, PMID 21314851, PMID 21350201, PMID 21468780, PMID 21514552, PMID 21748502, PMID 21834970, PMID 21947244, PMID 22088800, PMID 22254118, PMID 22328549, PMID 22374130, PMID 22889440, PMID 22889462, PMID 22965994, PMID 23099292, PMID 23295631, PMID 24323051, PMID 24440284, PMID 24548697, PMID 24762139, PMID 25152604, PMID 25394810, PMID 25427288, PMID 25495745, PMID 25592477, PMID 25965838, PMID 26002818, PMID 26063762, PMID 26485549

NIH funding

P50MD017356 (1)